Medical Devices Investors & VC Firms in United Kingdom
193 firms in this list, with a median first check of $571.5K. 43 of them lead rounds. Generated from verified public data and updated continuously.
Angels 5K
WinchesterSeed
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
33 people
SV Health Investors
BostonPre-Seed–Late Stage$1M – $20M
30 people
Elaia
ParisSeed–Growth$108K – $1.6M
44 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
47 people
HongShan Capital Group
Hong KongPre-Seed–Late Stage$100K – $50M
46 people
Advent International
BostonSeries A–Late Stage$1.1B
61 people
Artesian
SydneyPre-Seed–Late Stage$20M
39 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
12 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
36 people
360 Capital
MilanPre-Seed–Series B$162K – $10.8M
30 people
Hercules Capital, Inc.
San MateoSeed–Late Stage$5M – $500M
56 people
Eight Roads Ventures
MumbaiSeed–Late Stage$5M – $30M
20 people
Korys
HalleSeries A–Late Stage$5.4M
40 people
Taiwania Capital
TaipeiSeed–Growth$3M – $85M
46 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
42 people
Norrsken VC
StockholmSeed–Growth$1.1M – $3.2M
25 people
Oxford Finance LLC
AlexandriaSeed–Late Stage$5M – $125M
45 people
HealthCap
StockholmSeed–Growth
34 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
M Ventures
Los AngelesSeed–Growth$10.8M
6 people
Nina Capital
BarcelonaPre-Seed–Series A$215K – $1.6M
18 people
Panacea Venture
SingaporePre-Seed–Late Stage
22 people
Trendlines Group
MisgavPre-Seed–Late Stage$650K – $15M
18 people
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.




































































































